Podcast & Webinars

Interview with Dr. Chrystal Louis

April 8th, 2016
TWiPO hosts and co-hosts interview Dr. Chrystal Louis about her role in both the academic and industry side of oncology.

Interview with Dr. Kim Kramer

September 18, 2015
TWiPO hosts interview Dr. Kim Kramer about her research on a new way to treat brain tumors.

Linda McAllister-Lucas

July 24, 2015
TWiPO hosts and co-hosts talk with Dr. Linda McAllister-Lucas about her research on MALT1 Lymphoma and the effects this research can have on oncology.

TWiPO #52 ~ Interview with Dr. James Geller

July 10, 2015
TWiPO hosts interview Dr. James Geller, an original member of the TWiPO team. For this episode Dr. Geller talks about a new drug that could have a huge impact for oncology research and the process it takes to get access to these drugs.

TWIPO #51 ~ Interview with Dr. Gregory Armstrong

May 15, 2015
TWiPO hosts interview Dr. Gregory Armstrong, who talks about the Childhood Cancer Survival Study and how much we have advanced in the recent years in childhood cancer research.

TWIPO #50 ~ Interview with Dr. Jonathan Finlay

May 8, 2015
TWiPO host Dr. Timothy Cripe interviews Dr. Jonathan Finlay. He talks about how he launched a new treatment, which is able to rescue a proportion of newly diagnosed children who failed conventional treatment.

TWIPO #49 ~ Interview With Dr. Robin Norris

April 20, 2015
TWiPO co-hosts interview Robin Norris. Dr. Norris discusses the struggles that adolescents and young adults with cancer face. As well as discussing her involvement in creating an antibody against TEM-1 to stop the metastasis of tumors.

TWIPO #48 ~ Interview With Dr. Michael D. Hogarty

April 13, 2015
TWiPO host interviews Dr. Michael D. Hogarty. Dr. Hogarty talks about his efforts in finding a new way of tackling neuroblastoma. In this interview he discusses his current work in the lab which involves the MYC gene.

TWIPO #47 ~ Interview With Dr. Hiro Shimada

March 23, 2015
TWiPO co-hosts interview Hiroyuki Shimada. In this episode he discusses the development of the Shimada neuroblastoma classification system for neuroblastoma.